Lansing Street Advisors Abbott Laboratories Transaction History

Lansing Street Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $201 - $224	2 Added 0.2%	1,006 $109,000
Q1 2023 Apr 28, 2023	BUY	$96.86 - $114.01 $193 - $228	2 Added 0.2%	1,004 $101,000
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $190 - $223	2 Added 0.2%	1,002 $110,000
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $96 - $112	1 Added 0.1%	1,000 $97,000
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $102 - $123	1 Added 0.1%	999 $109,000
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $113,791 - $138,761	998 New	998 $123,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Lansing Street Advisors, based on Form 13F filings with the SEC.

Stay updated on Lansing Street Advisors with notifications on news.